UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 21, 2020

 

 

Kewaunee Scientific Corporation

(Exact name of registrant as specified in its charter)

 

Delaware   0-5286   38-0715562
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (I.R.S. Employer
Identification No.)

 

2700 West Front Street

Statesville, North Carolina

  28677
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code:    704-873-7202

N/A

(Former name or former address, if changed since last report.)

 

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange
on which registered

Common Stock, $2.50 par value   KEQU   NASDAQ Global Market

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 


Item 5.03

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

(a)    On April 21, 2020, the Board of Directors of Kewaunee Scientific Corporation (the “Company”) amended Sections 4.04 and 4.05 of the Bylaws of the Company to facilitate the Company holding remote or virtual stockholder meetings, including adjourned stockholder meetings, as a result of ongoing concerns and uncertainty about the COVID-19 pandemic. This description of the amendments is qualified in its entirety by reference to the complete text of the amended Bylaws of the Company, a copy of which is filed herewith as Exhibit 3 and incorporated herein by reference.

 

Item 9.01

Financial Statements and Exhibits.

(d)    Exhibits

 

Exhibit
Number

  

Description

3    Bylaws of Kewaunee Scientific Corporation, as amended on April 21, 2020


Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

                    (Registrant)
    Kewaunee Scientific Corporation
Date: April 27, 2020       /s/ Donald T. Gardner III
      Donald T. Gardner III
     

Vice President, Finance and

Chief Financial Officer

Kewaunee Scientific (NASDAQ:KEQU)
Historical Stock Chart
From Nov 2020 to Dec 2020 Click Here for more Kewaunee Scientific Charts.
Kewaunee Scientific (NASDAQ:KEQU)
Historical Stock Chart
From Dec 2019 to Dec 2020 Click Here for more Kewaunee Scientific Charts.